Wai Yuen Tong Medicine Holdings Limited (0897.HK)
HKD 0.21
(-0.48%)
HKD 0.21
(-0.48%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 353.93 Million HKD | -36.57% |
| 2022 | 557.98 Million HKD | 7.72% |
| 2021 | 517.99 Million HKD | 9.84% |
| 2020 | 471.58 Million HKD | 13.18% |
| 2019 | 416.67 Million HKD | 43.5% |
| 2018 | 290.36 Million HKD | -47.18% |
| 2017 | 549.74 Million HKD | 14.19% |
| 2016 | 481.43 Million HKD | 18.38% |
| 2015 | 406.68 Million HKD | -0.05% |
| 2014 | 406.88 Million HKD | 11.8% |
| 2013 | 363.95 Million HKD | 14.85% |
| 2012 | 316.9 Million HKD | 13.91% |
| 2011 | 278.19 Million HKD | 8.52% |
| 2010 | 256.34 Million HKD | 15.45% |
| 2009 | 222.04 Million HKD | -1.01% |
| 2008 | 224.29 Million HKD | 47.88% |
| 2007 | 151.67 Million HKD | -17.08% |
| 2006 | 182.92 Million HKD | 0.53% |
| 2005 | 181.95 Million HKD | -13.84% |
| 2004 | 211.19 Million HKD | 13.94% |
| 2003 | 185.34 Million HKD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 259.09 Million HKD | 0.0% |
| 2023 FY | 353.93 Million HKD | -36.57% |
| 2023 Q4 | 77.58 Million HKD | 0.0% |
| 2022 Q2 | 265.69 Million HKD | 0.0% |
| 2022 FY | 557.98 Million HKD | 7.72% |
| 2022 Q4 | 292.29 Million HKD | 0.0% |
| 2021 Q4 | 269.63 Million HKD | 0.0% |
| 2021 FY | 517.99 Million HKD | 9.84% |
| 2021 Q2 | 244.49 Million HKD | 0.0% |
| 2020 Q4 | 278.69 Million HKD | 0.0% |
| 2020 Q2 | 192.66 Million HKD | 0.0% |
| 2020 FY | 471.58 Million HKD | 13.18% |
| 2019 FY | 416.67 Million HKD | 43.5% |
| 2019 Q4 | 227.37 Million HKD | 0.0% |
| 2019 Q2 | 181 Million HKD | 0.0% |
| 2018 FY | 290.36 Million HKD | -47.18% |
| 2018 Q4 | 153.45 Million HKD | 0.0% |
| 2018 Q2 | 136.9 Million HKD | 0.0% |
| 2017 Q2 | 238.06 Million HKD | 0.0% |
| 2017 Q4 | 311.67 Million HKD | 0.0% |
| 2017 FY | 549.74 Million HKD | 14.19% |
| 2016 Q4 | 253.2 Million HKD | 0.0% |
| 2016 Q2 | 228.23 Million HKD | 0.0% |
| 2016 FY | 481.43 Million HKD | 18.38% |
| 2015 Q2 | 129.38 Million HKD | 0.0% |
| 2015 Q4 | 277.3 Million HKD | 0.0% |
| 2015 FY | 406.68 Million HKD | -0.05% |
| 2014 Q2 | 175.79 Million HKD | 93.21% |
| 2014 FY | 406.88 Million HKD | 11.8% |
| 2014 Q3 | 101.72 Million HKD | -42.14% |
| 2014 Q4 | 101.72 Million HKD | 0.0% |
| 2014 Q1 | 90.98 Million HKD | 0.0% |
| 2013 FY | 363.95 Million HKD | 14.85% |
| 2013 Q4 | 90.98 Million HKD | 0.0% |
| 2013 Q3 | 90.98 Million HKD | -38.68% |
| 2013 Q2 | 148.37 Million HKD | 87.28% |
| 2013 Q1 | 79.22 Million HKD | 0.0% |
| 2012 Q1 | 69.54 Million HKD | 0.0% |
| 2012 Q2 | 69.54 Million HKD | 0.0% |
| 2012 Q3 | 79.22 Million HKD | 13.91% |
| 2012 Q4 | 79.22 Million HKD | 0.0% |
| 2012 FY | 316.9 Million HKD | 13.91% |
| 2011 Q1 | 64.08 Million HKD | 0.0% |
| 2011 FY | 278.19 Million HKD | 8.52% |
| 2011 Q4 | 69.54 Million HKD | 0.0% |
| 2011 Q3 | 69.54 Million HKD | 8.52% |
| 2011 Q2 | 64.08 Million HKD | 0.0% |
| 2010 Q4 | 64.08 Million HKD | 0.0% |
| 2010 FY | 256.34 Million HKD | 15.45% |
| 2010 Q1 | 55.51 Million HKD | 0.0% |
| 2010 Q2 | 55.51 Million HKD | 0.0% |
| 2010 Q3 | 64.08 Million HKD | 15.45% |
| 2009 Q1 | 56.07 Million HKD | 0.0% |
| 2009 Q2 | 56.07 Million HKD | 0.0% |
| 2009 Q3 | 55.51 Million HKD | -1.01% |
| 2009 FY | 222.04 Million HKD | -1.01% |
| 2009 Q4 | 55.51 Million HKD | 0.0% |
| 2008 Q2 | 37.91 Million HKD | 0.0% |
| 2008 Q4 | 56.07 Million HKD | 0.0% |
| 2008 Q3 | 56.07 Million HKD | 47.88% |
| 2008 Q1 | 37.91 Million HKD | 0.0% |
| 2008 FY | 224.29 Million HKD | 47.88% |
| 2007 Q2 | 45.73 Million HKD | 0.0% |
| 2007 Q1 | 45.73 Million HKD | 0.0% |
| 2007 FY | 151.67 Million HKD | -17.08% |
| 2007 Q4 | 37.91 Million HKD | 0.0% |
| 2007 Q3 | 37.91 Million HKD | -17.08% |
| 2006 Q3 | 45.73 Million HKD | 0.53% |
| 2006 Q2 | 45.48 Million HKD | 0.0% |
| 2006 Q1 | 45.48 Million HKD | 0.0% |
| 2006 FY | 182.92 Million HKD | 0.53% |
| 2006 Q4 | 45.73 Million HKD | 0.0% |
| 2005 Q3 | 45.48 Million HKD | -13.84% |
| 2005 FY | 181.95 Million HKD | -13.84% |
| 2005 Q1 | 52.79 Million HKD | 0.0% |
| 2005 Q2 | 52.79 Million HKD | 0.0% |
| 2005 Q4 | 45.48 Million HKD | 0.0% |
| 2004 Q4 | 52.79 Million HKD | 0.0% |
| 2004 Q1 | 46.33 Million HKD | 0.0% |
| 2004 FY | 211.19 Million HKD | 13.94% |
| 2004 Q3 | 52.79 Million HKD | 13.94% |
| 2004 Q2 | 46.33 Million HKD | 0.0% |
| 2003 Q3 | 46.33 Million HKD | 0.0% |
| 2003 FY | 185.34 Million HKD | 0.0% |
| 2003 Q4 | 46.33 Million HKD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -1349.12% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | 90.832% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -896.237% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -1969.542% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | 40.112% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | 71.201% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | 29.7% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -63.382% |
| SSY Group Limited | 1.98 Billion HKD | 82.131% |
| JBM (Healthcare) Limited | 163.87 Million HKD | -115.976% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | -23.172% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 98.794% |